|
Symbol
|
RLLAEV | COMBKB | RLLACV | RLLAIV | RLLAAV | LBQWDU | RLLABV | Z0C8AZ | LCBFDU | RLLAFV |
|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible with European Knock-In | Barrier Reverse Convertible | Barrier Reverse Convertible |
|
Sous-jacent
|
Eli Lilly & Co. | Eli Lilly & Co. / Novo Nordisk AS (B) / Pfizer Inc. Basket | Eli Lilly & Co. | Eli Lilly & Co. | Eli Lilly & Co. | Eli Lilly & Co. | Eli Lilly & Co. | Eli Lilly & Co. | Eli Lilly & Co. | Eli Lilly & Co. |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
15.09.2026 | 24.08.2026 | 27.07.2026 | 17.08.2026 | 18.11.2026 | 04.08.2027 | 26.02.2027 | 11.09.2026 | 08.10.2027 | 07.05.2027 |
| Ratio | 0,902706 | - | 0,770078 | 0,649051 | 0,970403 | 0,204759 | 0,507965 | 0,501785 | 0,954563 | 0,925609 |
|
Prix d'exercise
|
- | - | - | - | - | - | - | - | - | - |
| rendement max. p.a. | 3,03% | - | - | -0,10% | 4,08% | 9,16% | 6,95% | 3,28% | 8,36% | 7,47% |
| Demande | - | 60,59 | - | - | - | - | - | - | - | - |
| Offre | - | - | - | - | - | - | - | - | - | - |